<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/444901</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>New Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Biochemistry</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain (AL) amyloidosis patient</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Swuec</surname>
<given-names>Paolo</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="author-notes" rid="n1">&#x0023;</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lavatelli</surname>
<given-names>Francesca</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="author-notes" rid="n1">&#x0023;</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tasaki</surname>
<given-names>Masayoshi</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Paissoni</surname>
<given-names>Cristina</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rognoni</surname>
<given-names>Paola</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maritan</surname>
<given-names>Martina</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brambilla</surname>
<given-names>Francesca</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Milani</surname>
<given-names>Paolo</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mauri</surname>
<given-names>Pierluigi</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Camilloni</surname>
<given-names>Carlo</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Palladini</surname>
<given-names>Giovanni</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Merlini</surname>
<given-names>Giampaolo</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ricagno</surname>
<given-names>Stefano</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9253-5170</contrib-id>
<name>
<surname>Bolognesi</surname>
<given-names>Martino</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Dipartimento di Bioscienze, Universit&#x00E0; degli Studi di Milano</institution>, 20133 Milano, <country>Italy</country></aff>
<aff id="a2"><label>2</label><institution>Centro di Ricerca Pediatrica Romeo ed Enrica Invernizzi, Universit&#x00E0; degli Studi di Milano</institution>, 20133 Milano, <country>Italy</country></aff>
<aff id="a3"><label>3</label><institution>Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia</institution>, 27100, Pavia, <country>Italy</country></aff>
<aff id="a4"><label>4</label><institution>Institute for Biomedical Technologies (ITB-CNR)</institution>, 20090 Segrate, Italy</aff>
</contrib-group>
<author-notes>
<fn id="n1" fn-type="equal"><label>&#x0023;</label><p>These authors contributed equally to this study</p></fn>
<corresp id="cor1"><label>&#x002A;</label>Correspondence and requests for materials should be addressed to S.R. (<email>stefano.ricagno@unimi.it</email>) and M.B. (<email>martino.bolognesi@unimi.it</email>)</corresp></author-notes>
<pub-date pub-type="epub">
<year>2018</year>
</pub-date>
<elocation-id>444901</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>10</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>16</day>
<month>10</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2018, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="444901.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<p>Systemic light chain (AL) amyloidosis is a life-threatening disease caused by aggregation and deposition of monoclonal immunoglobulin light chains (LC) in target organs. Severity of heart involvement is the most important factor determining prognosis. Here, we report the 4.0 &#x00C5; resolution cryo-electron microscopy (cryo-EM) map and structural model of amyloid fibrils extracted from the heart of an AL patient affected by severe amyloid cardiomyopathy. The fibrils are composed of one asymmetric protofilament, showing typical 4.9 &#x00C5; stacking and parallel cross-&#x03B2; architecture. Two distinct polypeptide stretches belonging to the LC variable domain (V<sub>l</sub>) could be modelled in the density (total of 77 residues), stressing the role of the V<sub>l</sub> domain in fibril assembly and LC aggregation. Despite high levels of V<sub>l</sub> sequence variability, residues stabilising the observed fibril core are conserved through several V<sub>l</sub> domains, highlighting structural motifs that may be common to misfolded LCs. Our data shed first light on the architecture of life-threatening LC amyloid deposits, and provide a rationale for correlating LC amino acid sequences and fibril structures.</p>
</abstract>
<counts>
<page-count count="9"/>
</counts>
</article-meta>
</front>
<body>
<p>Light chain (AL) amyloidosis, with an incidence of about 10 new cases per million-persons/year, is currently the most common systemic form of amyloidosis in Western countries<sup><xref ref-type="bibr" rid="c1">1</xref></sup>. The disease is associated with the presence of a plasma cell clone, and is caused by extracellular deposition of misfolding-prone monoclonal immunoglobulin light chains (LCs), transported to target organs through blood. Deposition of amyloid fibrils is associated with dysfunction of affected organs. The amino acid sequence of each patient&#x2019;s monoclonal LC is virtually unique, as a consequence of immunoglobulin germline genes rearrangement and somatic hypermutation. Fibril deposition in AL is widespread, and can target different organs; heart involvement dramatically worsens patients&#x2019; prognosis<sup><xref ref-type="bibr" rid="c2">2</xref>&#x2013;<xref ref-type="bibr" rid="c4">4</xref></sup>. Much research is currently being devoted to defining the molecular bases of amyloid cardiomyopathy<sup><xref ref-type="bibr" rid="c5">5</xref>&#x2013;<xref ref-type="bibr" rid="c7">7</xref></sup>, to hinder fibrillogenesis<sup><xref ref-type="bibr" rid="c8">8</xref></sup> and cell damage<sup><xref ref-type="bibr" rid="c5">5</xref>,<xref ref-type="bibr" rid="c9">9</xref>,<xref ref-type="bibr" rid="c10">10</xref></sup>.</p>
<p>LC subunits (<italic>ca.</italic> 215 residues) consist of two &#x03B2;-sandwich domains, each hosting a disulphide bridge: the highly variable N-terminal domain (V<sub>l</sub>; <italic>ca.</italic> 110 residues), a short joining region (J<sub>l</sub>), and the C-terminal constant domain (C<sub>l</sub>)<sup><xref ref-type="bibr" rid="c6">6</xref>,<xref ref-type="bibr" rid="c11">11</xref></sup>. Both full-length LCs and isolated V<sub>l</sub> domains are typical components of the deposited fibrils<sup><xref ref-type="bibr" rid="c12">12</xref>,<xref ref-type="bibr" rid="c13">13</xref></sup>; nonetheless, the mechanisms promoting aggregation <italic>in vivo</italic> remain unclear. Progress in understanding LC aggregation is hampered by lack of structural insight on AL fibrils, only low-resolution characterisation of LC fibrils being available to date<sup><xref ref-type="bibr" rid="c14">14</xref>,<xref ref-type="bibr" rid="c15">15</xref></sup>.</p>
<p>Cryo-EM proved as a first-choice method for structural analyses of amyloid aggregates prepared <italic>in vitro</italic> or extracted <italic>ex vivo</italic><sup><xref ref-type="bibr" rid="c16">16</xref>&#x2013;<xref ref-type="bibr" rid="c20">20</xref></sup>. Notably, in the few reported cases, the fibril component protein was shown to adopt complex folds, compatible but not fully predictable from fibril models based on short peptides<sup><xref ref-type="bibr" rid="c21">21</xref></sup>. Here we report the cryo-EM structure, at overall resolution of 4.0 &#x00C5;, of <italic>ex vivo</italic> heart LC fibrils from a patient affected by severe cardiac amyloidosis.</p>
<p>In order to define the structure of natural amyloid fibrils, we extracted and characterized <italic>ex vivo</italic> amyloid aggregates from the affected heart tissue. Specifically, fibrils were isolated from left ventricle specimens acquired during autopsy from a male patient affected by AL &#x03BB; amyloidosis, with severe amyloid cardiomyopathy (<xref ref-type="fig" rid="fig1"><bold>Fig.</bold> 1A</xref> and Extended Data <bold>Table</bold> 1). The monoclonal amyloidogenic LC, labelled as AL55, was sequenced from its coding mRNA from bone marrow plasma cells; AL55 is of &#x03BB; isotype and belongs to the <italic>IGLV6-57</italic> germline gene.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1&#x007C;</label>
<caption>
<title>Structure of AL55 fibrils from heart tissue.</title>
<p><bold>a</bold>, Myocardial tissue from patient AL55, stained with Congo red. Red-orange stain and apple-green birefringence indicate amyloid deposits under visible (left) and under polarized light (right), respectively. <bold>b</bold>, 2D-PAGE analysis of purified AL55 LC fibrils (inset from Extended Data <xref ref-type="fig" rid="fig1"><bold>Fig</bold>. 1b</xref>, left panel). Low and high MW fragments comprise residues from the N-<italic>terminus</italic> to residue 129, and to 150, respectively. <bold>c</bold>, Representative cryo-EM micrograph of AL55 LC fibrils; orange arrows highlight fibril cross-overs. <bold>d</bold>, Reference-free 2D class averages of AL55 fibril showing distinct cross-&#x03B2; staggering (green arrows). <bold>e</bold>, Overview of the AL55 fibril cryo-EM map covering the structured fibril core region (blue). <bold>f</bold>, Cross-sectional EM densities of sharpened, 4.0 &#x00C5; (blue) and unsharpened, 4.5 &#x00C5; low-pass filtered (grey) reconstructions.</p>
</caption>
<graphic xlink:href="444901_fig1.tif"/>
</fig>
<p>The molecular composition of the isolated fibrils was analysed by a proteomic approach, based on two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) coupled to nano-liquid chromatography tandem mass spectrometry (nLC-MS/MS). In agreement with previous observations <sup><xref ref-type="bibr" rid="c12">12</xref>,<xref ref-type="bibr" rid="c13">13</xref></sup>, fibrils are composed of a heterogeneous population of LC proteoforms and N-terminal fragments (<xref ref-type="fig" rid="fig1"><bold>Fig.</bold> 1b</xref> and Extended Data <xref ref-type="fig" rid="fig1"><bold>Fig</bold>. 1b</xref>). The LC fragments with lower molecular weight are predominant, and mainly contain the V<sub>l</sub> domain. However, longer fragments, extending through the constant domain, and species consistent with the full length LC are also present. Low molecular weight fragments are resistant to limited proteolysis (Extended Data <xref ref-type="fig" rid="fig1">Fig. 1b</xref>), whereas degradation of the longer proteoforms is observed, suggesting protection or burial of the V<sub>l</sub> domain within the fibril.</p>
<p>Contrary to previous reports<sup><xref ref-type="bibr" rid="c14">14</xref></sup>, our negative staining electron microscopy and cryo-EM analyses of freshly extracted amyloid material revealed no polymorphs (<xref ref-type="fig" rid="fig1"><bold>Fig</bold>. 1c</xref> and Extended Data <xref ref-type="fig" rid="fig2"><bold>Fig</bold>. 2</xref>). AL55 fibrils display a helical pitch of 1070 &#x00B1; 30 &#x00C5;, and 80 - 175 &#x00C5; width range (Extended Data <xref ref-type="fig" rid="fig2"><bold>Fig</bold>. 2</xref>). Absence of two symmetric protofilaments is evident from inspection of the fibrils in raw micrographs and in images obtained by reference-free 2D classification of segments comprising an entire helical pitch (<bold>Fig</bold>. 1c and Extended Data <xref ref-type="fig" rid="fig2"><bold>Fig</bold>. 2</xref>). 2D class averages of vitrified AL55 fibrils, where &#x03B2;-strands are clearly resolved, suggest the presence of a highly ordered core surrounded by low order regions (<xref ref-type="fig" rid="fig1"><bold>Fig</bold>. 1d</xref> and Extended Data <xref ref-type="fig" rid="fig2"><bold>Fig</bold>. 2</xref>).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2&#x007C;</label>
<caption>
<title>V<sub>l</sub> domain structured fragment in the fibril core.</title>
<p><bold>a,</bold> Sequence of AL55 V<sub>l</sub> domain: scheme of the secondary structure elements of the natively folded LC (N, blue), and of the fibril assembly (F, yellow), respectively; dashed lines correspond to residues non-modelled in the EM density. Residues are coloured according to their intrinsic aggregation propensities, as defined by CamSol<sup><xref ref-type="bibr" rid="c22">22</xref></sup> (high, in red; low, in black; very low in blue). <bold>b,</bold> Overview of AL55 fibril helical reconstruction (left) and cross-sectional densities (right). Atomic model of AL55 (residues 1-37 and 66-105) superimposed on a cross-section of the EM density map. <bold>c,</bold> Ribbon representation of the fibril structured core, rainbow coloured. Four stacks (subunits) in the typical cross-&#x03B2; arrangement are shown. <bold>d,</bold> A horizontal plane (perpendicular to the fibril elongation axis) is added in this ribbon representation of the fibril core to highlight the raise of each subunit at the end of &#x03B2;2 (P15) and of &#x03B2;5 (W36), respectively.</p>
</caption>
<graphic xlink:href="444901_fig2.tif"/>
</fig>
<p>Cryo-EM 3D reconstruction of AL55 fibrils resulted in a map at overall resolution of 4.0 &#x00C5;, in which the cross-&#x03B2; structure was clearly resolved (<xref ref-type="fig" rid="fig1"><bold>Fig</bold>. 1e-f</xref> and Extended Data <xref ref-type="fig" rid="fig3"><bold>Fig</bold>. 3</xref>). Consistent with our 2D analyses, the AL55 map showed a core whose consecutive &#x03B2;-strand rungs are related by helical symmetry, with a rise of 4.9 &#x00C5;, a twist of approximately &#x2013; 1.6&#x00B0;, and two low-order outer regions.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3&#x007C;</label>
<caption>
<title>Interactions and interfaces in the fibril core.</title>
<p><bold>a,</bold> A 2D schematic view of the core polypeptide stretches. Residues are coloured as follows: grey hydrophobic, cyan polar, red and blue negatively and positively charged, respectively. <bold>b,</bold> Stick representation of the fibril core together with a surface representation coloured according to electrostatic charges. <bold>c-d,</bold> A structural view of the fibril ends: the inner core (&#x03B2;1- &#x03B2;2) of the fibril is shown protruding from the surface (ridge; <bold>c</bold>); inner core concave region (groove) is shown in <bold>d</bold>.</p>
</caption>
<graphic xlink:href="444901_fig3.tif"/>
</fig>
<p>For each LC subunit deposited along the fibril axis, the structured core is divided into two segments: the central part of the density displays a &#x2018;snail-shell&#x2019; trace that is surrounded by a second, &#x2018;C-shaped&#x2019;, extended polypeptide stretch (<xref ref-type="fig" rid="fig1"><bold>Fig.</bold> 1f</xref>). The two regions are spatially contiguous but not directly connected by interpretable density, indicating that two distinct LC segments build the fibril core. Several bulky side-chains visible in the map, together with the C22-C91 disulphide bridge, supported chain tracing and modelling for 77 residues of AL55 V<sub>l</sub>. As a result, the first N-terminal 37 residues map into the internal snail-shell region, while the outer C-shaped stretch hosts residues 66-105 (<xref ref-type="fig" rid="fig2"><bold>Fig.</bold> 2a-b</xref>).</p>
<p>Individual LC subunits assemble with a parallel &#x03B2;-sheet topology along the fibril elongation axis, <italic>i.e.</italic> along the inter-subunit H-bonding direction. Each subunit presents nine &#x03B2;-strands; &#x03B2;1-&#x03B2;5 belong to the snail-shell region, and &#x03B2;6-&#x03B2;9 pack around it in the C-shaped stretch (<xref ref-type="fig" rid="fig2"><bold>Fig.</bold> 2c</xref> and <xref ref-type="fig" rid="fig3">3a</xref>). In particular, &#x03B2;1, &#x03B2;3, &#x03B2;5 and &#x03B2;6 face each other and tightly pack their side chains together, while &#x03B2;4, &#x03B2;7 and &#x03B2;9 form a second contact region of lower side chain packing density.</p>
<p>As previously reported for other amyloid fibril structures<sup>16-18,20,23</sup>, the &#x03B2;1-&#x03B2;5 modelled fragment does not display a planar arrangement in the fibril, the snail shell region adopting a &#x03B2;-helix-like structure. In particular, the polypeptide chain of subunit <italic>i</italic> rises twice, at residues P14 (<italic>i</italic>&#x002B;1) and at W36 (<italic>i</italic>&#x002B;2), such that the side chains from &#x03B2;1 of subunit <italic>i</italic> pack against the C-terminal residues of subunit <italic>i</italic>-2 (<xref ref-type="fig" rid="fig2"><bold>Fig.</bold> 2d</xref>). On the contrary, the C-shaped region (&#x03B2;6-&#x03B2;9) lays essentially in a plane; given that it is covalently bound to the snail shell region through the C22-C91 disulphide bond, this segment in molecule <italic>i</italic> is located at <italic>i</italic>&#x002B;1 level (<xref ref-type="fig" rid="fig2"><bold>Fig.</bold> 2d</xref>). Such overall assembly produces non-planar fibril ends. Analogously to what has been discussed for amyloid-&#x03B2; (1-42) fibrils<sup><xref ref-type="bibr" rid="c18">18</xref></sup>, the two ends of a fibril present a groove and a ridge (<xref ref-type="fig" rid="fig3"><bold>Fig.</bold> 3c-d</xref>), both of which expose highly hydrophobic patches (&#x03B2;1- &#x03B2;3 interface). Conceivably, the edge strand &#x03B2;1 of a natively folded LC could be recruited by the hydrophobic groove/ridge of a growing fibril, promoting unfolding and association of a new subunit.</p>
<p>Overall the AL55 segments that build the rigid fibril core are characterised by a few charged residues (9 out of 77), four of which are involved in two salt bridges (K16-D95, K82-E84) alleviating Coulombic repulsion (<xref ref-type="fig" rid="fig3"><bold>Fig.</bold> 3b</xref>). The 82-88 segment, which comprises most of the charged residues, is detached from the inner fibril core (<xref ref-type="fig" rid="fig3"><bold>Fig.</bold> 3b</xref>) and may prove accessible to water molecules. The V<sub>l</sub> stretches predicted to be most aggregation prone<sup><xref ref-type="bibr" rid="c22">22</xref></sup> are all comprised in the fibril core (<xref ref-type="fig" rid="fig3"><bold>Fig.</bold> 2a</xref>) that hosts two hydrophobic clusters. The first cluster builds the &#x03B2;1 - &#x03B2;3 interface (F2, L4, L18, I20), while the second is located between the &#x03B2;4-&#x03B2;5 turn and &#x03B2;6-&#x03B2;7 (I29, L76, I78, L81) (<xref ref-type="fig" rid="fig3"><bold>Fig.</bold> 3a</xref>), and includes the disulphide bond linking &#x03B2;4 to &#x03B2;7. The two Pro residues in the fibril core (P7 and P14) help forming the &#x03B2;1-&#x03B2;2 and &#x03B2;2-&#x03B2;3 turns, respectively. In the native V<sub>l</sub> immunoglobulin fold P7 is located at the centre of the edge &#x03B2;1-strand that is bulged; notably, such bulged edge strands are held to protect against amyloid aggregation<sup><xref ref-type="bibr" rid="c24">24</xref></sup>. Nevertheless, in the AL55 fibril core P7 conveniently accommodates in the &#x03B2;-&#x03B2;2 turn.</p>
<p>Besides the core region, AL55 fibrils present two areas of lower order: the first falls between residues 37 and 66 of the structured segments (<xref ref-type="fig" rid="fig1"><bold>Fig.</bold> 1f</xref> and <xref ref-type="fig" rid="fig2">2b</xref>). As limited proteolysis suggests that the whole V<sub>l</sub> domain is hosted in the fibril core, we postulate that the 38-65 polypeptide fills the low order region adjacent to residues 37 and 66. The 38-65 sequence hosts residues with low &#x03B2; propensity (four Pro and three Gly) and seven charged residues, which might prevent the formation of regular &#x03B2;-structures. The second poorly structured zone surrounds the last modelled residue (G105) (<xref ref-type="fig" rid="fig1"><bold>Fig.</bold> 1f</xref>). Mass spectrometry analysis shows that the fibrils contain also portions of the C<sub>l</sub> domain (that would follow beyond G105 in the intact LC). Such C<sub>l</sub> portions, which host residues with low aggregation propensity, would fill the poorly defined density region next to the C-end of the modelled polypeptide.</p>
<p>The LC fibril model, here presented, shows that two AL55 hypervariable complementarity determining regions (CDR) build the structured fibril core. CDR1 (T23-Q35) spans &#x03B2;3 through &#x03B2;4; CDR3 (Q92-V101) falls at the C-end of the modelled fibril core. Such observations highlight sequence variability of V<sub>l</sub> domains as a key factor not only for protein instability and aggregation propensity, but also for the molecular interactions stabilising fibril assembly. Thus, questions arise on how common such fibril architecture might be for AL deposits due to LCs other than AL55. The following structural considerations can be drawn.</p>
<p>Firstly, AL55 solubilised fibrils provide a typical pattern in 2D-PAGE: the fragments of lower molecular weight and higher abundance consist just of the V<sub>l</sub> domain; longer fragments always contain the LC N-terminal region<sup><xref ref-type="bibr" rid="c13">13</xref></sup>, strongly suggesting that the V<sub>l</sub> domain is required to build the fibril core. To assess whether other LCs may be compatible with the fibril architecture here reported, AL55 sequence was aligned with eight diverse cardiotoxic &#x03BB; LCs (Extended Data <bold>Fig.</bold> 4) previously reported<sup><xref ref-type="bibr" rid="c6">6</xref></sup>. Despite sequence variability, the residues that appear to play structuring roles in AL55 fibrils are conserved or conservatively mutated. A N-terminal stretch of hydrophobic residues, building the fibril inner &#x03B2;1, is present in all sequences (<xref ref-type="fig" rid="fig3"><bold>Fig</bold>. 3</xref> and Extended Data <bold>Fig</bold>. 4). In several LCs an extra Pro residue (P8) can be found, which would be located in the &#x03B2;1-&#x03B2;2 turn. G15, which in the AL55 fibril core adopts a conformation unfavourable for other amino acids, is conserved in all sequences. The conserved disulphide bond is a strong structural restrain. The two hydrophobic clusters stabilizing the AL55 fibrils can be achieved in all eight &#x03BB; LCs. Finally, several aromatic residues that stabilise the fibril through inter-subunit stacking interactions, and the (82-88) segment comprising charged residues, are present in all sequences (<xref ref-type="fig" rid="fig3"><bold>Fig</bold>. 3</xref> and Extended Data <bold>Fig</bold>. 4). As observed for two Tau protein isoforms that display different fibril subunit folds<sup><xref ref-type="bibr" rid="c16">16</xref>,<xref ref-type="bibr" rid="c17">17</xref></sup>, sequence variability of the V<sub>l</sub> domains might also result in some fibril structural rearrangements. Nevertheless, our cryo-EM results on <italic>ex-vivo</italic> cardiac amyloids suggest that structural motifs in the AL55 fibril architecture are compatible with the assembly of amyloid deposit from different LCs, and possibly in other organs, opening the way to a deeper molecular characterisation of AL amyloidosis.</p>
</body>
<back>
<sec>
<title>Data availability</title>
<p>Final AL55 cryo-EM map has been deposited to the Electron Microscopy Data Bank (code EMD-0274). Refined atomic model has been deposited to the Protein Data Bank (code 6HUD). The datasets generated and/or analysed during the current study are available from the corresponding authors upon reasonable request.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>Contributions from the University of Milano and Fondazione Romeo and Enrica Invernizzi, to founding the cryo-EM facility are gratefully acknowledged. This work was supported by Fondazione Cariplo (grants n. 2015-0591 and 2016-0489); Associazione Italiana per la Ricerca sul Cancro special program &#x201C;5 per mille&#x201D; (number 9965); the Italian Ministry of Health (grants RF-2013-02355259 and RF-2016-02361756), Italian Medicines Agency (grant AIFA-2016- 02364602), and E-Rare JTC 2016 grant ReDox. We are grateful to Laura Verga and Gianluca Capello for immuno-electron microscopy imaging.</p>
</ack>
<sec>
<title>Author contributions</title>
<p>P.S., F.L., MT, C.P., P.M., P.R., M.M., F.B., performed the experiments; P.S., F.L., S.R. designed the experiments; P.S., F.L., C.C., P.M. G.P., G.M., M.B., S.R. wrote the paper with contributions from all other Authors.</p>
</sec>
<sec sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>1</label><mixed-citation publication-type="journal"><string-name><surname>Wechalekar</surname>, <given-names>A. D.</given-names></string-name>, <string-name><surname>Gillmore</surname>, <given-names>J. D.</given-names></string-name> &#x0026; <string-name><surname>Hawkins</surname>, <given-names>P. N.</given-names></string-name> <article-title>Systemic amyloidosis</article-title>. <source>Lancet</source> <volume>387</volume>, <fpage>2641</fpage>&#x2013;<lpage>2654</lpage>, doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(15)01274-X</pub-id> (<year>2016</year>).</mixed-citation></ref>
<ref id="c2"><label>2</label><mixed-citation publication-type="journal"><string-name><surname>Merlini</surname>, <given-names>G.</given-names></string-name> <article-title>AL amyloidosis: from molecular mechanisms to targeted therapies</article-title>. <source>Hematology. American Society of Hematology. Education Program</source> <volume>2017</volume>, <fpage>1</fpage>&#x2013;<lpage>12</lpage>, doi:<pub-id pub-id-type="doi">10.1182/asheducation-2017.1.1</pub-id> (<year>2017</year>).</mixed-citation></ref>
<ref id="c3"><label>3</label><mixed-citation publication-type="journal"><string-name><surname>Merlini</surname>, <given-names>G.</given-names></string-name> &#x0026; <string-name><surname>Palladini</surname>, <given-names>G.</given-names></string-name> <article-title>Light chain amyloidosis: the heart of the problem</article-title>. <source>Haematologica</source> <volume>98</volume>, <fpage>1492</fpage>&#x2013;<lpage>1495</lpage>, doi:<pub-id pub-id-type="doi">10.3324/haematol.2013.094482</pub-id> (<year>2013</year>).</mixed-citation></ref>
<ref id="c4"><label>4</label><mixed-citation publication-type="journal"><string-name><surname>Palladini</surname>, <given-names>G.</given-names></string-name> <etal>et al.</etal> <article-title>New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes</article-title>. <source>J Clin Oncol</source> <volume>30</volume>, <fpage>4541</fpage>&#x2013;<lpage>4549</lpage>, doi:<pub-id pub-id-type="doi">10.1200/JCO.2011.37.7614</pub-id> (<year>2012</year>).</mixed-citation></ref>
<ref id="c5"><label>5</label><mixed-citation publication-type="journal"><string-name><surname>Lavatelli</surname>, <given-names>F.</given-names></string-name> <etal>et al.</etal> <article-title>Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosis</article-title>. <source>FASEB journal: official publication of the Federation of American Societies for Experimental Biology</source> <volume>29</volume>, <fpage>4614</fpage>&#x2013;<lpage>4628</lpage>, doi:<pub-id pub-id-type="doi">10.1096/fj.15-272179</pub-id> (<year>2015</year>).</mixed-citation></ref>
<ref id="c6"><label>6</label><mixed-citation publication-type="journal"><string-name><surname>Oberti</surname>, <given-names>L.</given-names></string-name> <etal>et al.</etal> <article-title>Concurrent structural and biophysical traits link with immunoglobulin light chains amyloid propensity</article-title>. <source>Sci Rep</source> <volume>7</volume>, <fpage>16809</fpage>, doi:<pub-id pub-id-type="doi">10.1038/s41598-017-16953-7</pub-id> (<year>2017</year>).</mixed-citation></ref>
<ref id="c7"><label>7</label><mixed-citation publication-type="journal"><string-name><surname>Sapp</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Jain</surname>, <given-names>M.</given-names></string-name> &#x0026; <string-name><surname>Liao</surname>, <given-names>R.</given-names></string-name> <article-title>Viewing Extrinsic Proteotoxic Stress Through the Lens of Amyloid Cardiomyopathy</article-title>. <source>Physiology</source> <volume>31</volume>, <fpage>294</fpage>&#x2013;<lpage>299</lpage>, doi:<pub-id pub-id-type="doi">10.1152/physiol.00047.2015</pub-id> (<year>2016</year>).</mixed-citation></ref>
<ref id="c8"><label>8</label><mixed-citation publication-type="journal"><string-name><surname>Brumshtein</surname>, <given-names>B.</given-names></string-name> <etal>et al.</etal> <article-title>Inhibition by small-molecule ligands of formation of amyloid fibrils of an immunoglobulin light chain variable domain</article-title>. <source>eLife</source> <volume>4</volume>, <fpage>e10935</fpage>, doi:<pub-id pub-id-type="doi">10.7554/eLife.10935</pub-id> (<year>2015</year>).</mixed-citation></ref>
<ref id="c9"><label>9</label><mixed-citation publication-type="journal"><string-name><surname>Guan</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal> <article-title>Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity</article-title>. <source>EMBO molecular medicine</source> <volume>6</volume>, <fpage>1493</fpage>&#x2013;<lpage>1507</lpage>, doi:<pub-id pub-id-type="doi">10.15252/emmm.201404190</pub-id> (<year>2014</year>).</mixed-citation></ref>
<ref id="c10"><label>10</label><mixed-citation publication-type="journal"><string-name><surname>Marin-Argany</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal> <article-title>Cell Damage in Light Chain Amyloidosis: FIBRIL INTERNALIZATION, TOXICITY AND CELL-MEDIATED SEEDING</article-title>. <source>J Biol Chem</source> <volume>291</volume>, <fpage>19813</fpage>&#x2013;<lpage>19825</lpage>, doi:<pub-id pub-id-type="doi">10.1074/jbc.M116.736736</pub-id> (<year>2016</year>).</mixed-citation></ref>
<ref id="c11"><label>11</label><mixed-citation publication-type="journal"><string-name><surname>Blancas-Mejia</surname>, <given-names>L. M.</given-names></string-name> <etal>et al.</etal> <article-title>Immunoglobulin light chain amyloid aggregation</article-title>. <source>Chemical communications</source> <volume>54</volume>, <fpage>10664</fpage>&#x2013;<lpage>10674</lpage>, doi:<pub-id pub-id-type="doi">10.1039/c8cc04396e</pub-id> (<year>2018</year>).</mixed-citation></ref>
<ref id="c12"><label>12</label><mixed-citation publication-type="journal"><string-name><surname>Enqvist</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Sletten</surname>, <given-names>K.</given-names></string-name> &#x0026; <string-name><surname>Westermark</surname>, <given-names>P.</given-names></string-name> <article-title>Fibril protein fragmentation pattern in systemic AL-amyloidosis</article-title>. <source>The Journal of pathology</source> <volume>219</volume>, <fpage>473</fpage>&#x2013;<lpage>480</lpage>, doi:<pub-id pub-id-type="doi">10.1002/path.2607</pub-id> (<year>2009</year>).</mixed-citation></ref>
<ref id="c13"><label>13</label><mixed-citation publication-type="journal"><string-name><surname>Lavatelli</surname>, <given-names>F.</given-names></string-name> <etal>et al.</etal> <article-title>Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue</article-title>. <source>Molecular &#x0026; cellular proteomics: MCP</source> <volume>7</volume>, <fpage>1570</fpage>&#x2013;<lpage>1583</lpage>, doi:<pub-id pub-id-type="doi">10.1074/mcp.M700545-MCP200</pub-id> (<year>2008</year>).</mixed-citation></ref>
<ref id="c14"><label>14</label><mixed-citation publication-type="journal"><string-name><surname>Annamalai</surname>, <given-names>K.</given-names></string-name> <etal>et al.</etal> <article-title>Common Fibril Structures Imply Systemically Conserved Protein Misfolding Pathways In Vivo</article-title>. <source>Angewandte Chemie</source> <volume>56</volume>, <fpage>7510</fpage>&#x2013;<lpage>7514</lpage>, doi:<pub-id pub-id-type="doi">10.1002/anie.201701761</pub-id> (<year>2017</year>).</mixed-citation></ref>
<ref id="c15"><label>15</label><mixed-citation publication-type="journal"><string-name><surname>Close</surname>, <given-names>W.</given-names></string-name> <etal>et al.</etal> <article-title>Physical basis of amyloid fibril polymorphism</article-title>. <source>Nature communications</source> <volume>9</volume>, <fpage>699</fpage>, doi:<pub-id pub-id-type="doi">10.1038/s41467-018-03164-5</pub-id> (<year>2018</year>).</mixed-citation></ref>
<ref id="c16"><label>16</label><mixed-citation publication-type="journal"><string-name><surname>Falcon</surname>, <given-names>B.</given-names></string-name> <etal>et al.</etal> <article-title>Structures of filaments from Pick&#x2019;s disease reveal a novel tau protein fold</article-title>. <source>Nature</source> <volume>561</volume>, <fpage>137</fpage>&#x2013;<lpage>140</lpage>, doi:<pub-id pub-id-type="doi">10.1038/s41586-018-0454-y</pub-id> (<year>2018</year>).</mixed-citation></ref>
<ref id="c17"><label>17</label><mixed-citation publication-type="journal"><string-name><surname>Fitzpatrick</surname>, <given-names>A. W. P.</given-names></string-name> <etal>et al.</etal> <article-title>Cryo-EM structures of tau filaments from Alzheimer&#x2019;s disease</article-title>. <source>Nature</source> <volume>547</volume>, <fpage>185</fpage>&#x2013;<lpage>190</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nature23002</pub-id> (<year>2017</year>).</mixed-citation></ref>
<ref id="c18"><label>18</label><mixed-citation publication-type="journal"><string-name><surname>Gremer</surname>, <given-names>L.</given-names></string-name> <etal>et al.</etal> <article-title>Fibril structure of amyloid-beta(1-42) by cryo-electron microscopy</article-title>. <source>Science</source> <volume>358</volume>, <fpage>116</fpage>&#x2013;<lpage>119</lpage>, doi:<pub-id pub-id-type="doi">10.1126/science.aao2825</pub-id> (<year>2017</year>).</mixed-citation></ref>
<ref id="c19"><label>19</label><mixed-citation publication-type="journal"><string-name><surname>Guerrero-Ferreira</surname>, <given-names>R.</given-names></string-name> <etal>et al.</etal> <article-title>Cryo-EM structure of alpha-synuclein fibrils</article-title>. <source>eLife</source> <volume>7</volume>, doi:<pub-id pub-id-type="doi">10.7554/eLife.36402</pub-id> (<year>2018</year>).</mixed-citation></ref>
<ref id="c20"><label>20</label><mixed-citation publication-type="journal"><string-name><surname>Liberta</surname>, <given-names>F.</given-names></string-name> <etal>et al.</etal> <article-title>Cryo-EM structure of an amyloid fibril from systemic amyloidosis</article-title>. <source>bioRxiv</source>, <fpage>1</fpage>&#x2013;<lpage>37</lpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="c21"><label>21</label><mixed-citation publication-type="journal"><string-name><surname>Nelson</surname>, <given-names>R.</given-names></string-name> <etal>et al.</etal> <article-title>Structure of the cross-beta spine of amyloid-like fibrils</article-title>. <source>Nature</source> <volume>435</volume>, <fpage>773</fpage>&#x2013;<lpage>778</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nature03680</pub-id> (<year>2005</year>).</mixed-citation></ref>
<ref id="c22"><label>22</label><mixed-citation publication-type="journal"><string-name><surname>Sormanni</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Aprile</surname>, <given-names>F. A.</given-names></string-name> &#x0026; <string-name><surname>Vendruscolo</surname>, <given-names>M.</given-names></string-name> <article-title>The CamSol method of rational design of protein mutants with enhanced solubility</article-title>. <source>J Mol Biol</source> <volume>427</volume>, <fpage>478</fpage>&#x2013;<lpage>490</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.jmb.2014.09.026</pub-id> (<year>2015</year>).</mixed-citation></ref>
<ref id="c23"><label>23</label><mixed-citation publication-type="journal"><string-name><surname>Heinig</surname>, <given-names>M.</given-names></string-name> &#x0026; <string-name><surname>Frishman</surname>, <given-names>D.</given-names></string-name> <article-title>STRIDE: a web server for secondary structure assignment from known atomic coordinates of proteins</article-title>. <source>Nucleic acids research</source> <volume>32</volume>, <fpage>W500</fpage>&#x2013;<lpage>502</lpage>, doi:<pub-id pub-id-type="doi">10.1093/nar/gkh429</pub-id> (<year>2004</year>).</mixed-citation></ref>
<ref id="c24"><label>24</label><mixed-citation publication-type="journal"><string-name><surname>Richardson</surname>, <given-names>J. S.</given-names></string-name> &#x0026; <string-name><surname>Richardson</surname>, <given-names>D. C.</given-names></string-name> <article-title>Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>99</volume>, <fpage>2754</fpage>&#x2013;<lpage>2759</lpage> (<year>2002</year>).</mixed-citation></ref>
</ref-list>
</back>
</article>